MYNAVCARE PATIENT SUPPORT
LIVE

Serial Number

97936772

Owner

Genmab A/S

Attorney

Max Vern

First Use Date

May 31, 2023

Filing Date

May 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MYNAVCARE PATIENT SUPPORT Trademark

Serial Number: 97936772 • Registration: 7819913

MYNAVCARE PATIENT SUPPORT is a trademark filed by Genmab A/S on May 15, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Genmab A/S (46 trademarks)

Carl Jacobsens Vej 30

Entity Type: 98

Trademark Details

Filing Date

May 15, 2023

Registration Date

June 3, 2025

First Use Anywhere

May 31, 2023

First Use in Commerce

May 31, 2023

Published for Opposition

March 19, 2024

Goods & Services

Financial administration of patient reimbursement and patient financial assistance programs, namely reimbursement payment processing in the field of pharmaceutical and medical claims; Charitable services, namely, providing financial support to disadvantaged patients for the purpose of reimbursing medical and pharmaceutical expenses; Providing counseling and consulting in the field of healthcare insurance benefits in connection with patient reimbursement and patient financial assistance programs; Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries

Provision of consumer information in the field of patient reimbursement and medical benefit support; Business administrative services for medical referrals in connection to patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries

Providing personal support services for patients and families of patients in connection to disease management and navigation through medical treatments, namely, emotional counseling and emotional support; Providing personal support services for families of patients with life threatening disorders in connection to disease management and reimbursement of medical expenses, namely, companionship, help with medical forms, emotional counseling and emotional support; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries

Medical assistance, namely disease management programs; provision of health care information in connection to disease management and navigation through medical treatments; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients in connection with disease management; Consultancy in the field of the medical treatment of cancer, autoimmune diseases, and inflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields in connection to disease management and navigation through medical treatments; health care services, namely disease management programs; medical and pharmaceutical consultation in connection to disease management; medical services, namely, provision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients in relation to the reimbursement of medical expenses; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 3, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 3, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 9, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 9, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2025 CRFA
ASSIGNED TO LIE
Apr 25, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 13, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 13, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 23, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 23, 2025 AITU
USE AMENDMENT FILED
Nov 7, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 7, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 14, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 15, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 15, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 15, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 15, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 15, 2024 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 17, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 11, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 13, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 13, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 13, 2023 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2023 NWOS
NEW APPLICATION ENTERED
May 18, 2023 NWAP